Apreo Health | $130,000,000 | (Aug 12, 2025)
Orbital Operations | $8,800,000 | (Aug 12, 2025)
Perle | $9,000,000 | (Aug 12, 2025)
Certified by Founder
Lodge
Indapta Therapeutics
start up
United States
- Seattle & Houston
- 18/12/2024
- Unknown
- $22,500,000
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
- Industry Biotechnology
- Website https://indapta.com/
- LinkedIn https://www.linkedin.com/company/indapta-therapuetics/
Edumentors | $2,000,000 | (Aug 12, 2025)
August Health | $29,000,000 | (Aug 12, 2025)
BinSentry | $50,000,000 | (Aug 12, 2025)
Lava | $5,800,000 | (Aug 12, 2025)
Certivity | $15,458,285 | (Aug 12, 2025)
Swirltex Inc. | $1,200,000 | (Aug 12, 2025)
Tahoe Therapeutics | $30,000,000 | (Aug 12, 2025)
Translucent(US) | $7,000,000 | (Aug 12, 2025)
Elion | $9,300,000 | (Aug 7, 2025)